Roivant Sciences Ltd.

ISIN BMG762791017

 | 

WKN A3C4MS

Market cap (in EUR)
22,700 m
Country
United Kingdom
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Show more Show less
Healthcare Healthcare Services Miscellaneous Healthcare United Kingdom

Financials

Key metrics

Market capitalisation, EUR 22,700 m
EPS, EUR -0.38
P/B ratio 6.2
P/E ratio 1.9
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 7 m
Net income, EUR -259 m
Profit margin -3,629.19%

What ETF is Roivant Sciences Ltd. in?

There are 6 ETFs which contain Roivant Sciences Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Roivant Sciences Ltd. is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 1.78%
Equity
United States
Health Care
Biotech
67
Vanguard Russell 1000 U.S. Value UCITS ETF USD Dist 0.05%
Equity
United States
Value
2
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.02%
Equity
World
Social/Environmental
609
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.03%
Equity
North America
Social/Environmental
28
Vanguard Russell U.S. Mid-Cap UCITS ETF USD Dist 0.12%
Equity
United States
Mid Cap
3
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.24%
Equity
United States
Small Cap
237
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.